ALC:NYSE
Alcon AG
74,50 USD
0,00%
(0,00) 1 D
74,25 USD
arrow_downward
−0,34% (−0,25)todayFør børsåpning
Stengt: 19. nov., 16:00:04 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ALC …
Markedsverdi
31,28 mrd.
Snittvolum
2,43 mill.
Volum
32,36k
52 u høy
87,64 USD
52 u lav
61,84 USD
Beta
0,87
Utestående aksjer
480,40 mill.
Antall ansatte
25k
Markedsverdi
31,28 mrd.
Snittvolum
2,43 mill.
Volum
32,36k
52 u høy
87,64 USD
52 u lav
61,84 USD
Beta
0,87
Utestående aksjer
480,40 mill.
Antall ansatte
25k
Nyhetssaker
Fra nettkilder og nyhetspartnere
TradingView
·
for 7 timer siden
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
for 16 timer siden
Why Pershing Square Is Betting Big on Alcon Stock
Zacks
·
for 2 døgn siden
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Om Alcon AG
Administrerende direktørDavid J. Endicott
Ansatte25k
Grunnlagt1945
HovedkontorGenève, Genève, Sveits
SektorHealth Care
Bransje-
Nettstedalcon.com